focalinterest.net

Tag: Psychiatry & Clinical Mental Health

  • SSTICS complaints are higher in schizophrenia but weakly tied to cognition

    What the study found

    The study found that people with schizophrenia reported more cognitive complaints than healthy controls, but these complaints were not meaningfully linked to objective cognition. The authors also found that the complaints were more closely associated with depressive symptoms and only weakly with illness insight.

    Why the authors say this matters

    The authors conclude that these findings suggest SSTICS-based complaints may reflect emotional distress rather than actual cognitive deficits. They also suggest the results support refining SSTICS subscales and extending study of this tool to other psychiatric populations.

    What the researchers tested

    The researchers conducted a meta-analysis following PRISMA guidelines, using systematic searches of PubMed, Web of Science, and Google Scholar. They included studies that used the Subjective Scale to Investigate Cognition in Schizophrenia, compared patients with healthy controls, examined correlations with cognition, symptoms, or illness insight, or analyzed the scale's factor structure.

    What worked and what didn't

    Twenty-five studies with 3,205 participants met the criteria. Schizophrenia patients reported more cognitive complaints than controls (d = 0.746), but there was no significant correlation with global objective cognition (r = 0.105), and complaints were unrelated to positive, negative, or general symptoms. There was a moderate association with depressive symptoms (r = 0.300), a small association with illness insight (r = 0.155), and factor analyses consistently identified three domains: memory, attention, and daily living.

    What to keep in mind

    The abstract does not describe detailed limitations beyond the scope of the included studies. The findings are specific to studies using the SSTICS in psychiatric populations, so the summary cannot be generalized beyond what the authors explicitly report.

    • Twenty-five studies with 3,205 participants were included in the meta-analysis.
    • People with schizophrenia reported more cognitive complaints than healthy controls.
    • Cognitive complaints were not significantly related to global objective cognition.
    • Complaints were moderately associated with depressive symptoms and weakly associated with illness insight.
    • Factor analyses consistently showed three SSTICS domains: memory, attention, and daily living.

  • Speech features tracked symptom severity in schizophrenia

    What the study found

    The study found that naturalistic speech in people with schizophrenia carried specific, interpretable signs of symptom severity. The speech-based models could estimate symptoms with clinically meaningful accuracy and these patterns were replicated in a U.S. cohort.

    Why the authors say this matters

    The authors conclude that speech-based modeling provides a basis for scalable, low-burden tools for real-time monitoring in psychosis. They also state that quantitative speech analysis is not yet integrated into clinical care, despite speech being used in psychiatric assessment.

    What the researchers tested

    The researchers conducted a longitudinal, multicenter cohort study in adult patients with schizophrenia spectrum disorders in the Netherlands, with replication in a U.S. cohort. They analyzed repeated speech and clinical assessments, using the Positive and Negative Syndrome Scale (PANSS) in the Dutch cohort and the Brief Psychiatric Rating Scale in the U.S. cohort, and converted speech into AI-derived voice and text features reduced with principal component analysis.

    What worked and what didn't

    In the Dutch cohort, item-level symptom estimates were within less than 1 point on a 1-to-7 scale, which the authors describe as clinically meaningful. Models were associated with PANSS positive and negative subscale scores, and in the U.S. replication cohort, thought disturbance and withdrawal scores were also associated with similar error levels and explained variance; negative symptoms were linked with reduced speech output and flatter acoustic profiles, while positive symptoms were linked with longer utterances and altered discourse organization.

    What to keep in mind

    The summary does not describe detailed limitations beyond the study being conducted in specific cohorts in the Netherlands and the U.S. The findings are based on cohort data and repeated assessments, so the abstract does not claim that the models are ready for routine clinical use.

    • Speech-based models detected individual psychotic symptoms with clinically meaningful accuracy in the Dutch cohort.
    • The Dutch cohort included 773 speech recordings from 356 participants; the U.S. replication cohort included 165 recordings from 72 participants.
    • PANSS positive and negative subscale scores were associated with the speech models in the Dutch cohort.
    • In the U.S. cohort, thought disturbance and withdrawal scores showed similar associations.
    • Negative symptoms were linked to reduced speech output and flatter acoustic profiles.
    • Positive symptoms were linked to longer utterances and altered discourse organization.

  • Digital app intervention improved quality of life in adults with ADHD

    What the study found

    The study found that adding an unguided digital intervention to usual care was associated with better health-related quality of life in adults with attention-deficit/hyperactivity disorder, or ADHD. It also found greater improvement in ADHD symptoms in the intervention group than in the control group.

    Why the authors say this matters

    The authors say unguided digital interventions may help lessen the treatment gap, because psychotherapy for adults with ADHD is still underused in Germany and worldwide. They also note that only a small percentage of these patients receive psychotherapy as recommended in guidelines.

    What the researchers tested

    The researchers ran an open-label, exploratory randomized controlled trial in adults with confirmed ADHD. Participants were recruited at six study centers in Germany and through social media, then randomly assigned to treatment as usual plus an app or to treatment as usual alone.

    What worked and what didn't

    At 12 weeks, health-related quality of life was better in the intervention group, and 40% of those participants reached a clinically relevant improvement compared with 27% of controls. ADHD symptoms improved more in the intervention group than in the control group, while adherence to the intervention was generally low.

    What to keep in mind

    The abstract says no standardized diagnostics were conducted within the study. It also states that no conclusions can be drawn about long-term effects.

    • Adults with confirmed ADHD were randomly assigned to an app plus usual care or usual care alone.
    • Health-related quality of life at 12 weeks was better in the intervention group.
    • Forty percent of the intervention group had clinically relevant quality-of-life improvement, compared with 27% of controls.
    • ADHD symptoms improved more in the intervention group than in the control group.
    • Adherence to the unguided intervention was generally low.
    • The abstract reports no standardized diagnostics and no conclusions about long-term effects.

  • Review finds neurophysiological markers remain established schizophrenia endophenotypes

    What the study found

    The review finds that oculomotor measures, event-related potentials, and cognitive deficits are supported as established endophenotypes for schizophrenia. Evidence for social cognition markers is more mixed, with Theory of Mind and emotion processing showing promise, but social perception and attributional bias remaining inconsistent.

    Why the authors say this matters

    The authors conclude that integrating these markers is relevant for stratified psychiatry and treatment personalization. They also suggest that some endophenotypes may reflect shared neural vulnerabilities across the schizoaffective spectrum.

    What the researchers tested

    The researchers conducted a narrative mini-review of recent evidence. They examined neurophysiological, neuropsychological, and social-cognitive parameters as candidate endophenotypes for schizophrenia, with endophenotypes defined as intermediate links between the disorder's polygenic architecture and clinical features.

    What worked and what didn't

    The review says there is ample evidence for oculomotor measures, event-related potentials, and cognitive deficits as endophenotypes found consistently in affected individuals and first-degree relatives. In social cognition, results are more heterogeneous: Theory of Mind and emotion processing appear promising, while evidence for social perception and attributional bias is inconsistent.

    What to keep in mind

    This is a narrative mini-review, so its conclusions depend on the studies it summarizes. The abstract notes that social cognition components still require further validation, and it does not provide detailed limitations beyond that.

    • Oculomotor measures, event-related potentials, and cognitive deficits are described as established schizophrenia endophenotypes.
    • Social cognition findings are mixed overall.
    • Theory of Mind and emotion processing are presented as promising candidate endophenotypes.
    • Evidence for social perception and attributional bias is inconsistent.
    • The authors link these markers to stratified psychiatry and treatment personalization.

  • Chinese stigma scale for persistent somatic symptoms shows good reliability

    What the study found

    The Chinese version of the Persistent Somatic Symptom Stigma Scale for Healthcare Professionals (a questionnaire for measuring stigma toward patients with persistent somatic symptoms, or long-lasting bodily symptoms without a clear cause) was found to have satisfactory reliability and validity. It contains 13 items in three dimensions: othering, uneasiness in interaction, and non-disclosure.

    Why the authors say this matters

    The authors conclude that this tool can be used to assess healthcare professionals’ stigma toward patients with persistent somatic symptoms in China. They also say it provides a measurement basis for developing interventions to reduce stigma, improve clinical attitudes, and inform policy-making in persistent somatic symptom management.

    What the researchers tested

    The researchers translated and cross-culturally adapted the original scale into Chinese using Brislin’s translation model, including forward translation, back-translation, expert review, and pretesting. They then tested the Chinese version in 282 healthcare professionals recruited from March to April 2025; 30 of them completed a retest after two weeks.

    What worked and what didn't

    Content validity was strong, with item-level content validity index values from 0.80 to 1.00 and a scale-level content validity index of 0.946. Exploratory factor analysis identified three factors explaining 66.692% of the total variance, with factor loadings between 0.743 and 0.885. Reliability was also acceptable to strong, with overall Cronbach’s alpha of 0.867, split-half reliability of 0.798, and test-retest reliability of 0.897.

    What to keep in mind

    The study used a convenience sample from one testing period, so the abstract does not describe broader population testing. No other limitations are described in the available summary.

    • The Chinese scale has 13 items across three dimensions: othering, uneasiness in interaction, and non-disclosure.
    • Content validity scores were high, with a scale-level CVI of 0.946.
    • Exploratory factor analysis supported three factors explaining 66.692% of the total variance.
    • Reliability measures were acceptable to strong, including test-retest reliability of 0.897.
    • The authors say the scale can support stigma assessment and intervention development in China.

  • Perceived constraints were linked to later depression and anxiety through coping

    What the study found

    The study found that perceived control over daily stressors was linked to later depression and anxiety symptoms, but the pattern depended on the type of perceived control, the coping strategy, and the disorder. In particular, perceived constraints were more consistently tied to later symptoms through coping, while mastery showed a more specific link to generalized anxiety disorder (GAD).

    Why the authors say this matters

    The authors conclude that these disorder-specific patterns highlight the importance of tailoring prevention strategies for major depressive disorder (MDD) and GAD. The study suggests that different forms of coping may help explain how perceived control relates to later mental health outcomes.

    What the researchers tested

    The researchers analyzed three-wave data from 3,294 participants in the Midlife Development in the United States (MIDUS) study, with waves about nine years apart. They used longitudinal structural equation modeling to test whether coping strategies at the second wave, divided into approach coping and avoidance coping, mediated the relationship between perceived control at the first wave and MDD and GAD symptoms at the third wave, while controlling for baseline symptom severity.

    What worked and what didn't

    Avoidance coping significantly mediated the pathway from perceived constraints to later MDD severity, while approach coping did not mediate that pathway. For GAD symptoms, both approach and avoidance coping mediated the link from perceived constraints, and approach coping fully mediated the link from mastery to later GAD severity; avoidance coping did not mediate the mastery pathway.

    What to keep in mind

    The summary does not describe limitations beyond the study design and the measured variables. The findings come from one cohort, use self-reported constructs of perceived control and coping, and describe associations over time rather than direct causal proof.

    • Perceived constraints were linked to later MDD symptoms through avoidance coping.
    • For GAD symptoms, both approach and avoidance coping mediated the constraints pathway.
    • Approach coping fully mediated the mastery-to-GAD pathway.
    • Neither coping strategy mediated the mastery-to-MDD pathway.
    • The authors say the patterns support tailoring prevention strategies for MDD and GAD.

  • SSTICS complaints are linked more to depression than cognition

    What the study found

    The meta-analysis found that people with schizophrenia reported more cognitive complaints than healthy controls. These complaints were not significantly related to global objective cognition, but they were more strongly linked to depressive symptoms and only weakly linked to illness insight.

    Why the authors say this matters

    The authors conclude that SSTICS-based complaints may reflect emotional distress rather than actual cognitive deficits. They also suggest that the findings support refining the SSTICS subscales and extending this line of research to other psychiatric populations.

    What the researchers tested

    The researchers conducted a meta-analysis following PRISMA guidelines, using systematic searches of PubMed, Web of Science, and Google Scholar. They included studies in psychiatric populations that used the Subjective Scale to Investigate Cognition in Schizophrenia (SSTICS), compared patients with healthy controls, examined correlations with cognition, symptoms, or illness insight, or performed factor analyses of SSTICS domains.

    What worked and what didn't

    Twenty-five studies with 3,205 participants met the criteria. Schizophrenia patients reported more cognitive complaints than controls, but complaints showed no significant correlation with global objective cognition and were unrelated to positive, negative, or general symptoms; they showed a moderate association with depressive symptoms and a small association with illness insight. Factor analyses consistently identified three domains: memory, attention, and daily living.

    What to keep in mind

    The summary does not describe limitations beyond the fact that the evidence comes from studies using the SSTICS. The review also focused on psychiatric populations and on the specific outcomes listed in the abstract.

    • People with schizophrenia reported more cognitive complaints than healthy controls.
    • Subjective complaints were not significantly correlated with global objective cognition.
    • Complaints were moderately associated with depressive symptoms and weakly associated with illness insight.
    • Factor analyses repeatedly found three SSTICS domains: memory, attention, and daily living.
    • The authors suggest the complaints may reflect emotional distress rather than actual deficits.

  • Neural activity predicted treatment response in internalizing disorders

    What the study found

    The review found that baseline neural activity during emotion regulation was often linked to treatment response in internalizing disorders such as depressive and anxiety disorders. In general, lower pre-treatment activity in medial and lateral prefrontal cortices during explicit regulation tasks was associated with greater symptom improvement, while higher baseline activity in prefrontal and anterior cingulate regions during implicit regulation tasks was often associated with greater symptom improvement.

    Why the authors say this matters

    The authors conclude that neural predictors of treatment outcome may contribute to precision medicine, meaning treatment could be better matched to patients. They also suggest that these predictors may help improve treatment outcomes in internalizing disorders.

    What the researchers tested

    This was a narrative review of functional magnetic resonance imaging studies, or fMRI studies that measure brain activity. The review examined studies of explicit emotion regulation, such as cognitive reappraisal or effortful regulation, and implicit emotion regulation, such as automatic regulation, in relation to treatment response for negative stimuli in internalizing disorders.

    What worked and what didn't

    Across the reviewed studies, treatments mostly included cognitive behavioral therapy, exposure therapy, and/or pharmacotherapy. For explicit regulation, pre-treatment activity in medial and lateral prefrontal cortices frequently predicted treatment response, and lower baseline activity was generally linked to greater symptom improvement. For implicit regulation, predictors often involved prefrontal cortical regions and the anterior cingulate cortex, with more baseline activity generally predicting greater symptom improvement; findings in other regions, including the amygdala, were less consistent.

    What to keep in mind

    The review notes substantial gaps in the literature. Most explicit regulation studies focused on cognitive reappraisal, and most studies involved major depressive disorder, anxiety disorders, and posttraumatic stress disorder, with insufficient representation of other internalizing disorders.

    • Baseline brain activity during emotion regulation was often associated with treatment response.
    • Lower pre-treatment activity in medial and lateral prefrontal cortices during explicit regulation was generally linked to greater symptom improvement.
    • Higher baseline activity in prefrontal and anterior cingulate regions during implicit regulation was generally linked to greater symptom improvement.
    • Most reviewed studies examined cognitive behavioral therapy, exposure therapy, and/or pharmacotherapy.
    • The literature was limited by a heavy focus on cognitive reappraisal and a few internalizing disorders.

  • Parents reported long, uncertain waits for ADHD assessment

    What the study found

    Parents described the wait for an attention-deficit/hyperactivity disorder (ADHD) assessment as a period of uncertainty and stress. The study identified concerns about communication from services, access to support, and the impact of waiting on children and families.

    Why the authors say this matters

    The authors conclude that parents' well-being could be improved by clearer information about wait times and more effective signposting and support during the assessment process. They suggest this may help reduce stressors such as feeling responsible for a child's difficulties and managing educational needs.

    What the researchers tested

    The researchers carried out semi-structured interviews with 41 parents of children aged 5 to 11 years. The study was nested within a large randomised controlled trial and used reflexive thematic analysis to examine parents' experiences while waiting after being accepted onto a Child and Adolescent Mental Health Services (CAMHS) waitlist.

    What worked and what didn't

    Around 30% of parents had waited 18 to 24 months, and 10% had waited more than 2 years. About half of the children were still waiting for an initial assessment at the time of interview. Six themes emerged, including uncertainty about the assessment process, lack of communication, the importance of diagnosis, difficulty accessing support, negative effects on mental health and education, and recommendations for better communication between services and families.

    What to keep in mind

    The findings come from interviews with parents in the U.K. and may not apply beyond this setting. The abstract does not describe detailed child outcomes, and it does not provide a comparison group for the interview findings.

    • Parents described the waiting period for ADHD assessment as uncertain and stressful.
    • Lack of communication from services was one of the main themes reported.
    • About half of the children were still waiting for an initial assessment at interview.
    • Thirty percent of parents had waited 18 to 24 months, and 10% had waited more than 2 years.
    • The authors say clearer wait-time information and better signposting could improve parent well-being.

  • Ethical tensions in action-research on mental health harm

    What the study found

    The paper argues that action-research in mental health settings can confront ethical tensions when researchers document suffering in systems that also pressure silence. It identifies institutional and legal barriers that can block accountability and keep harm hidden.

    Why the authors say this matters

    The authors say the findings support a shift toward ethically robust, open science infrastructures and dynamic, reflexive protocols. They conclude that researchers should be able to respond to harm ethically and structurally, so suffering is not made invisible for institutional comfort.

    What the researchers tested

    The paper is based on a five-year, multi-sited ethnographic inquiry across Spain, Italy, Sweden, and Indonesia. It combined lived experience, scientific fieldwork, participatory methods, first-hand documentation of abuse, and policy engagement at national and international levels.

    What worked and what didn't

    The study reports that dominant legal and institutional frameworks in Europe can obstruct accountability by shielding professionals through laws that protect subjective annotations, prevent access to clinical records, and frame complaints as symptoms. It presents these as barriers to open and ethically responsive qualitative research.

    What to keep in mind

    The abstract does not provide detailed outcome measures or comparative evaluation of specific interventions. Its claims are framed as an argument from qualitative and policy-engaged inquiry across the settings named in the abstract.

    • The paper argues that mental health research can expose harm while institutions demand silence.
    • It says European legal and institutional frameworks can block accountability in cases of alleged abuse.
    • The study draws on a five-year ethnographic inquiry in Spain, Italy, Sweden, and Indonesia.
    • The author advocates for open science infrastructures and reflexive research protocols.
    • The abstract describes the work as a framework for action-oriented, justice-driven qualitative research.